Tempia Valenta, Silvia https://orcid.org/0009-0002-6295-0741
Beghelli, Valentina
Marcolini, Federica
Rosinska, Magda
De Ronchi, Diana
Fernandez-Aranda, Fernando
Atti, Anna Rita
Funding for this research was provided by:
Departament de Salut, Generalitat de Catalunya (Departament de Salut, Generalitat de Catalunya)
Article History
Received: 21 February 2025
Accepted: 25 May 2025
First Online: 18 June 2025
Declarations
:
: F.F.A. received consultancy honoraria from Novo Nordisk.
: This study complied with the Declaration of Helsinki and with the Italian privacy law, specifically the ‘Code on the Protection of Personal Data (Legislative Decree 196/2003), updated with the new legislative decree (Legislative Decree 101/2018).’ The statistical evaluation of collected data was carried out after complete anonymization. The study was approved by the local Institutional Review Board. The Research Protocol with the identification number 87153 was officially approved on July 28, 2022.
: At the time of the assessment, all participants were asked to voluntarily provide written consent to use their clinical information for research purposes.
: We grant permission to reproduce the material from our work, provided it is properly credited to the original source.